219 related articles for article (PubMed ID: 24095028)
1. Genotype impact on HCV RNA levels determined with the VERSANT HCV RNA 1.0 assay (kPCR).
Kessler HH; Hübner M; Konrad PM; Stelzl E; Stübler MM; Baser MH; Santner BI
J Clin Virol; 2013 Nov; 58(3):522-7. PubMed ID: 24095028
[TBL] [Abstract][Full Text] [Related]
2. Impact of hepatitis C virus (HCV) genotypes on quantification of HCV RNA in serum by COBAS AmpliPrep/COBAS TaqMan HCV test, Abbott HCV realtime assay [corrected] and VERSANT HCV RNA assay.
Tuaillon E; Mondain AM; Ottomani L; Roudière L; Perney P; Picot MC; Séguret F; Blanc F; Larrey D; Van de Perre P; Ducos J
J Clin Microbiol; 2007 Sep; 45(9):3077-81. PubMed ID: 17581929
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the new VERSANT HIV-1 RNA 1.0 Assay (kPCR) for quantitative detection of human immunodeficiency virus type 1 RNA.
Troppan KT; Stelzl E; Violan D; Winkler M; Kessler HH
J Clin Virol; 2009 Sep; 46(1):69-74. PubMed ID: 19576845
[TBL] [Abstract][Full Text] [Related]
4. HCV RNA measurement in samples with diverse genotypes using versions 1 and 2 of the Roche COBAS® AmpliPrep/COBAS® TaqMan® HCV test.
Pyne MT; Mallory M; Hillyard DR
J Clin Virol; 2015 Apr; 65():54-7. PubMed ID: 25766989
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the Roche COBAS AmpliPrep/COBAS TaqMan HCV Test.
Pyne MT; Hillyard DR
Diagn Microbiol Infect Dis; 2013 Sep; 77(1):25-30. PubMed ID: 23806661
[TBL] [Abstract][Full Text] [Related]
6. Analytical characteristics and comparative evaluation of Aptima HCV quant Dx assay with the Abbott RealTime HCV assay and Roche COBAS AmpliPrep/COBAS TaqMan HCV quantitative test v2.0.
Worlock A; Blair D; Hunsicker M; Le-Nguyen T; Motta C; Nguyen C; Papachristou E; Pham J; Williams A; Vi M; Vinluan B; Hatzakis A
Virol J; 2017 Apr; 14(1):66. PubMed ID: 28372576
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis C virus RNA quantitation in a nationwide French cohort of patients co-infected with HIV and HCV: should the same test be applied to all samples?
Trimoulet P; Merchadou L; Winnock M; Loko MA; Fleury H; Salmon D; Dabis F; Neau D;
J Virol Methods; 2012 Apr; 181(1):131-3. PubMed ID: 22285372
[TBL] [Abstract][Full Text] [Related]
8. Performance evaluation of the new Roche cobas AmpliPrep/cobas TaqMan HCV test, version 2.0, for detection and quantification of hepatitis C virus RNA.
Pas S; Molenkamp R; Schinkel J; Rebers S; Copra C; Seven-Deniz S; Thamke D; de Knegt RJ; Haagmans BL; Schutten M
J Clin Microbiol; 2013 Jan; 51(1):238-42. PubMed ID: 23152551
[TBL] [Abstract][Full Text] [Related]
9. Clinical performance of the new rRoche COBAS TaqMan HCV Test and High Pure System for extraction, detection and quantitation of HCV RNA in plasma and serum.
Gelderblom HC; Menting S; Beld MG
Antivir Ther; 2006; 11(1):95-103. PubMed ID: 16518965
[TBL] [Abstract][Full Text] [Related]
10. TaqMan amplification system with an internal positive control for HCV RNA quantitation.
Castelain S; Descamps V; Thibault V; François C; Bonte D; Morel V; Izopet J; Capron D; Zawadzki P; Duverlie G
J Clin Virol; 2004 Nov; 31(3):227-34. PubMed ID: 15465417
[TBL] [Abstract][Full Text] [Related]
11. Fully automated quantification of hepatitis C virus (HCV) RNA in human plasma and human serum by the COBAS AmpliPrep/COBAS TaqMan system.
Sizmann D; Boeck C; Boelter J; Fischer D; Miethke M; Nicolaus S; Zadak M; Babiel R
J Clin Virol; 2007 Apr; 38(4):326-33. PubMed ID: 17344093
[TBL] [Abstract][Full Text] [Related]
12. Performance of two Real-Time RT-PCR assays for quantitation of hepatitis C virus RNA: evaluation on HCV genotypes 1-4.
Elkady A; Tanaka Y; Kurbanov F; Sugauchi F; Sugiyama M; Khan A; Ali EM; Mouhamed L; Abou el-fetouh S; AbdEl-Hameed AR; Mizokami M
J Med Virol; 2010 Nov; 82(11):1878-88. PubMed ID: 20872714
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the COBAS Hepatitis C Virus (HCV) TaqMan analyte-specific reagent assay and comparison to the COBAS Amplicor HCV Monitor V2.0 and Versant HCV bDNA 3.0 assays.
Konnick EQ; Williams SM; Ashwood ER; Hillyard DR
J Clin Microbiol; 2005 May; 43(5):2133-40. PubMed ID: 15872232
[TBL] [Abstract][Full Text] [Related]
14. A comparative evaluation between real time Roche COBas TAQMAN 48 HCV and bDNA Bayer Versant HCV 3.0.
Giraldi C; Noto A; Tenuta R; Greco F; Perugini D; Spadafora M; Bianco AM; Savino O; Natale A
New Microbiol; 2006 Oct; 29(4):243-50. PubMed ID: 17201090
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the COBAS(®) AmpliPrep/COBAS(®) TaqMan(®) HCV Test, v2.0 and comparison to assays used in routine clinical practice in an international multicenter clinical trial: The ExPECT study.
Kessler HH; Cobb BR; Wedemeyer H; Maasoumy B; Michel-Treil V; Ceccherini-Nelli L; Bremer B; Hübner M; Helander A; Khiri H; Heilek G; Simon CO; Luk K; Aslam S; Halfon P
J Clin Virol; 2015 Jun; 67():67-72. PubMed ID: 25959162
[TBL] [Abstract][Full Text] [Related]
16. Comparison of qualitative (COBAS AMPLICOR HCV 2.0 versus VERSANT HCV RNA) and quantitative (COBAS AMPLICOR HCV monitor 2.0 versus VERSANT HCV RNA 3.0) assays for hepatitis C virus (HCV) RNA detection and quantification: impact on diagnosis and treatment of HCV infections.
Desombere I; Van Vlierberghe H; Couvent S; Clinckspoor F; Leroux-Roels G
J Clin Microbiol; 2005 Jun; 43(6):2590-7. PubMed ID: 15956369
[TBL] [Abstract][Full Text] [Related]
17. Clinical evaluation of the COBAS Ampliprep/COBAS TaqMan for HCV RNA quantitation in comparison with the branched-DNA assay.
Pittaluga F; Allice T; Abate ML; Ciancio A; Cerutti F; Varetto S; Colucci G; Smedile A; Ghisetti V
J Med Virol; 2008 Feb; 80(2):254-60. PubMed ID: 18098148
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of performances of VERSANT HCV RNA 1.0 assay (kPCR) and Roche COBAS AmpliPrep/COBAS TaqMan HCV test v2.0 at low level viremia.
Mazzuti L; Lozzi MA; Riva E; Maida P; Falasca F; Antonelli G; Turriziani O
New Microbiol; 2016 Jul; 39(3):224-227. PubMed ID: 27284986
[TBL] [Abstract][Full Text] [Related]
19. Analytical and clinical performance of the Hologic Aptima HCV Quant Dx Assay for the quantification of HCV RNA in plasma samples.
Schønning K; Pedersen MS; Johansen K; Landt B; Nielsen LG; Weis N; Westh H
J Virol Methods; 2017 Oct; 248():159-165. PubMed ID: 28732692
[TBL] [Abstract][Full Text] [Related]
20. Differences between two real-time PCR-based hepatitis C virus (HCV) assays (RealTime HCV and Cobas AmpliPrep/Cobas TaqMan) and one signal amplification assay (Versant HCV RNA 3.0) for RNA detection and quantification.
Vermehren J; Kau A; Gärtner BC; Göbel R; Zeuzem S; Sarrazin C
J Clin Microbiol; 2008 Dec; 46(12):3880-91. PubMed ID: 18799708
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
